BIOTRUE MULTI-PURPOSE SOLUTION

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a consumer,health professional report with the FDA on 2016-11-18 for BIOTRUE MULTI-PURPOSE SOLUTION manufactured by Bausch & Lomb Incorporated.

Event Text Entries

[60333962] The complaint sample was returned and is currently pending evaluation. A review of the lot device history records is ongoing. Based on available information, no causal factors can be determined and no conclusion can be drawn.
Patient Sequence No: 1, Text Type: N, H10


[60333963] Consumer reported experiencing pain, blurred vision, and redness upon initial use of product. Consumer reported visiting emergency room and being diagnosed with chemical conjunctivitis in both eyes. Consumer was prescribed tobramycin. 3% ophthalmic solution and instructed to follow-up with her eye care professional. The consumer has not provided update on condition and has not provided indication of follow-up. Medical records have been requested but have not been received.
Patient Sequence No: 1, Text Type: D, B5


[62728342] Treating doctor reported that the complaint device caused or contributed to the event, however, the complaint sample was returned for evaluation and the results of the testing performed were all within specification. Additionally, a review of the lot batch record concluded that this product was formulated and manufactured according to local and global specifications. Based on available information, no causal factors can be determined and no conclusion can be drawn.
Patient Sequence No: 1, Text Type: N, H10


[62728343] Since the initial report dated 18-nov-2016, information obtained from the healthcare provider indicates the patient was diagnosed with bilateral chemical conjunctivitis. Per treating doctor, patient visited emergency department with bilateral eye injection and tearing. Patient stated that her symptoms began after using the contact lens solution in question. Patient was prescribed erythromycin ophthalmic ointment and tobramycin eye drops. Doctor reported patient is compliant with lens wear and care. The doctor reported that there was no permanent damage and noted that the patient is recovered. While medical documentation indicates patient is recovered, patient reports her eyes to still be red and dry.
Patient Sequence No: 1, Text Type: D, B5


[72905821] Based on available information, no causal factors can be determined and no conclusion can be drawn.
Patient Sequence No: 1, Text Type: N, H10


[72905822] Additional information obtained indicates that the consumer followed-up at an eye clinic two days following her visit to the emergency room. Optometrist who saw patient at eye clinic informed that the patient was seen in the emergency room for symptoms of ocular burning, redness, discharge, and blurred vision. Patient was treated and instructed to follow-up with the clinic. At time of her follow-up visit, the patient presented with burning, discharge, redness, and blurred vision. Optometrist diagnosed chemical conjunctivitis. It was noted that the cornea was not involved and that the examination was normal. Patient? S eyes appeared stable and optometrist recommended patient discontinue the medication provided by the emergency room. Optometrist noted that the patient was convinced that her symptoms were secondary to the contact lens solution in question and stated that the timing was compelling. Patient was then seen two weeks later for a comprehensive eye examination and there were no residual effects. Four months later, consumer visited an alternate eye clinic. Information obtained from this clinic indicates that the patient was seen with symptoms of floaters in both eyes. Cornea was not involved. Doctor diagnosed bilateral vitreous degeneration and bilateral myopia. Patient was only seen once at this clinic and was not provided with any medical intervention. Doctor opined that the likely cause of the event was age related vitreous degeneration. Clinic also noted that the patient has a history of vitreous degeneration and myopia. Both doctors indicated that the event was not considered life threatening, did not result in permanent damage to a body structure, and did not necessitate medical/surgical intervention in order to preclude permanent damage to a body structure.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number0001313525-2016-00609
MDR Report Key6112785
Report SourceCONSUMER,HEALTH PROFESSIONAL
Date Received2016-11-18
Date of Report2016-10-19
Date of Event2016-10-19
Date Mfgr Received2017-03-31
Device Manufacturer Date2016-06-20
Date Added to Maude2016-11-18
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationPATIENT
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMS. SHARON SPENCER
Manufacturer Street50 TECHNOLOGY DRIVE WEST
Manufacturer CityIRVINE CA 92618
Manufacturer CountryUS
Manufacturer Postal92618
Manufacturer Phone9493985698
Manufacturer G1BAUSCH + LOMB
Manufacturer Street8507 PELHAM ROAD
Manufacturer CityGREENVILLE SC 29615
Manufacturer CountryUS
Manufacturer Postal Code29615
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameBIOTRUE MULTI-PURPOSE SOLUTION
Generic NameACCESSORIES, SOLUTION, CLEANERS FOR LENSES
Product CodeLYL
Date Received2016-11-18
Returned To Mfg2016-11-01
Lot NumberGF16073
ID NumberNI
Device Expiration Date2018-06-30
OperatorLAY USER/PATIENT
Device AvailabilityR
Device AgeDA
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerBAUSCH & LOMB INCORPORATED
Manufacturer Address1400 NORTH GOODMAN STREET ROCHESTER NY 14609 US 14609


Patients

Patient NumberTreatmentOutcomeDate
101. Other 2016-11-18

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.